NO20085180L - Fremgangsmate og midler for behandling av inflammatorisk tarmsykdom - Google Patents

Fremgangsmate og midler for behandling av inflammatorisk tarmsykdom

Info

Publication number
NO20085180L
NO20085180L NO20085180A NO20085180A NO20085180L NO 20085180 L NO20085180 L NO 20085180L NO 20085180 A NO20085180 A NO 20085180A NO 20085180 A NO20085180 A NO 20085180A NO 20085180 L NO20085180 L NO 20085180L
Authority
NO
Norway
Prior art keywords
patient
inflammatory bowel
bowel disease
support agent
antibodies
Prior art date
Application number
NO20085180A
Other languages
English (en)
Norwegian (no)
Inventor
Magnus Thorn
Ola Winqvist
Original Assignee
Ibd Column Therapies Internat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ibd Column Therapies Internat filed Critical Ibd Column Therapies Internat
Publication of NO20085180L publication Critical patent/NO20085180L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20085180A 2006-05-12 2008-12-11 Fremgangsmate og midler for behandling av inflammatorisk tarmsykdom NO20085180L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0601075 2006-05-12
PCT/SE2007/000459 WO2007133147A1 (en) 2006-05-12 2007-05-14 Method and means for treating inflammatory bowel disease

Publications (1)

Publication Number Publication Date
NO20085180L true NO20085180L (no) 2008-12-11

Family

ID=38694153

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085180A NO20085180L (no) 2006-05-12 2008-12-11 Fremgangsmate og midler for behandling av inflammatorisk tarmsykdom

Country Status (21)

Country Link
US (1) US8449489B2 (zh)
EP (1) EP2021025B1 (zh)
JP (1) JP5266207B2 (zh)
KR (1) KR20090007642A (zh)
CN (1) CN101443041A (zh)
AU (1) AU2007250552B2 (zh)
CA (1) CA2651883C (zh)
CY (1) CY1118286T1 (zh)
DK (1) DK2021025T3 (zh)
EA (1) EA016851B1 (zh)
ES (1) ES2603203T3 (zh)
HU (1) HUE032241T2 (zh)
IL (1) IL195001A0 (zh)
LT (1) LT2021025T (zh)
NO (1) NO20085180L (zh)
PL (1) PL2021025T3 (zh)
PT (1) PT2021025T (zh)
SG (1) SG171684A1 (zh)
SI (1) SI2021025T1 (zh)
WO (1) WO2007133147A1 (zh)
ZA (1) ZA200809429B (zh)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA015989B1 (ru) 2005-08-31 2012-01-30 АйТиЭйч ИММЬЮН ТЕРАПИ ХОЛДИНГЗ АБ Лечение воспалительного заболевания кишечника
KR20090007642A (ko) 2006-05-12 2009-01-19 아이비디 컬럼 세라피스 인터네셔널 아베 염증성 장질환을 치료하기 위한 방법 및 수단
CA2695360A1 (en) * 2007-08-02 2009-02-05 Iss Immune System Stimulation Ab Diagnosis, staging and monitoring of inflammatory bowel disease
US8877177B2 (en) 2008-09-10 2014-11-04 Ith Immune Therapy Holdings Ab Chemokine containing apheresis column and methods of use
US11285494B2 (en) 2009-08-25 2022-03-29 Nanoshell Company, Llc Method and apparatus for continuous removal of sub-micron sized particles in a closed loop liquid flow system
US10099227B2 (en) 2009-08-25 2018-10-16 Nanoshell Company, Llc Method and apparatus for continuous removal of sub-micron sized particles in a closed loop liquid flow system
WO2012099721A2 (en) * 2011-01-18 2012-07-26 The Regents Of The University Of California Real-time adaptive immune system and method
US8979787B2 (en) * 2011-01-20 2015-03-17 Henry John Smith Treatment of pre-eclampsia using targeted apheresis
WO2012172337A2 (en) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Treating cardiovascular disease
US9726666B2 (en) 2011-06-13 2017-08-08 Tla Targeted Immunotherapies Ab Diagnosing and treating inflammatory diseases
WO2012172345A2 (en) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Treating conditions associated with allergy
WO2012172342A2 (en) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Treating multiple sclerosis
WO2012172340A2 (en) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Treating mental disorders
WO2012172336A2 (en) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Treating inflammatory skin diseases
EP2718312B1 (en) * 2011-06-13 2018-07-25 TLA Targeted Immunotherapies AB Treating conditions associated with sepsis
WO2012172343A2 (en) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Treating primary sclerosing cholangitis
EP2718313B1 (en) * 2011-06-13 2017-05-17 TLA Targeted Immunotherapies AB Treating respiratory conditions
WO2012172339A2 (en) * 2011-06-13 2012-12-20 Ith Immune Therapy Holdings Treating inflammatory arthritis
US10073097B2 (en) * 2012-11-28 2018-09-11 Charles C. Caldwell Diagnostic assays and methods of treating pneumonia, sepsis and systemic inflammatory response syndrome
WO2015158855A1 (en) 2014-04-16 2015-10-22 Genovie Ab Regulatory t-cells for use in the treatment of inflammatory disorders of the human gastrointestinal tract
EP3131559B1 (en) * 2014-04-16 2019-02-13 Genovie AB Cd8+ regulatory t-cells for use in the treatment of inflammatory disorders of the human gastrointestinal tract
WO2021063708A1 (en) * 2019-09-30 2021-04-08 Hemotune Ag Assembly for extracorporeal treatment of body fluids
WO2024122553A1 (ja) * 2022-12-05 2024-06-13 国立大学法人京都大学 潰瘍性大腸炎又は原発性硬化性胆管炎の治療方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS639449A (ja) 1986-07-01 1988-01-16 テルモ株式会社 血液成分分離用器具
JPH0649653B2 (ja) 1988-06-29 1994-06-29 テルモ株式会社 白血球分離材、分離器および分離方法
JPH02167071A (ja) 1988-12-19 1990-06-27 Terumo Corp 非ヒト動物由来白血球系細胞の分離材、分離器および分離方法
JPH0374A (ja) 1988-12-31 1991-01-07 Tonen Corp 白血球吸着分離材
JPH04187206A (ja) 1990-11-19 1992-07-03 Toyobo Co Ltd 白血球分離装置及び白血球分離材料の製造方法
US5728306A (en) 1994-12-23 1998-03-17 Baxter International Inc. Leukodepletion filter and method for filtering leukocytes from freshly drawn blood
DE19538641C2 (de) * 1995-10-05 2000-09-21 Privates Inst Bioserv Gmbh Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung
JPH1057477A (ja) 1996-08-26 1998-03-03 Asahi Medical Co Ltd 白血球除去フィルター材および白血球除去フィルター装置
JP4197545B2 (ja) * 1997-12-01 2008-12-17 旭化成クラレメディカル株式会社 特異的細胞除去材料
HUP0103563A3 (en) * 1998-08-31 2004-04-28 Biogen Idec Ma Inc Cambridge Method of modulating memory effector t-cells and compositions
GB0022748D0 (en) 2000-09-15 2000-11-01 Allied Therapeutics Ltd Reducing the content of cells in a biological sample
JP2003265596A (ja) 2002-03-12 2003-09-24 Asahi Kasei Corp 白血球選択吸着剤及びその評価選択方法
US6936222B2 (en) * 2002-09-13 2005-08-30 Kenneth L. Franco Methods, apparatuses, and applications for compliant membrane blood gas exchangers
US20060234210A1 (en) 2004-04-14 2006-10-19 Affinergy, Inc. Filtration device and method for removing selected materials from biological fluids
DE102005036505A1 (de) 2004-07-30 2006-06-01 Adexter Gmbh Vorrichtung und Verfahren zum Isolieren von Zellen, Biopartikeln und/oder Molekülen aus Flüssigkeiten mit dem Ziel einer Anwendung zur Behandlung von Krankheiten des Menschen
WO2006125201A2 (en) 2005-05-19 2006-11-23 Centocor, Inc. Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses
KR20090007642A (ko) 2006-05-12 2009-01-19 아이비디 컬럼 세라피스 인터네셔널 아베 염증성 장질환을 치료하기 위한 방법 및 수단
KR101398768B1 (ko) 2006-09-29 2014-05-27 도레이 카부시키가이샤 세포 흡착 컬럼

Also Published As

Publication number Publication date
US20090192434A1 (en) 2009-07-30
DK2021025T3 (en) 2016-12-12
EA016851B1 (ru) 2012-08-30
EP2021025B1 (en) 2016-08-17
JP5266207B2 (ja) 2013-08-21
JP2009536944A (ja) 2009-10-22
PT2021025T (pt) 2016-11-21
IL195001A0 (en) 2011-08-01
EP2021025A4 (en) 2010-08-18
ES2603203T3 (es) 2017-02-24
AU2007250552B2 (en) 2011-07-07
SG171684A1 (en) 2011-06-29
HUE032241T2 (en) 2017-09-28
CY1118286T1 (el) 2017-06-28
CN101443041A (zh) 2009-05-27
ZA200809429B (en) 2009-08-26
WO2007133147A1 (en) 2007-11-22
EA200802086A1 (ru) 2009-06-30
CA2651883C (en) 2017-05-30
EP2021025A1 (en) 2009-02-11
AU2007250552A1 (en) 2007-11-22
LT2021025T (lt) 2017-01-25
KR20090007642A (ko) 2009-01-19
CA2651883A1 (en) 2007-11-22
US8449489B2 (en) 2013-05-28
SI2021025T1 (sl) 2017-02-28
PL2021025T3 (pl) 2017-04-28

Similar Documents

Publication Publication Date Title
NO20085180L (no) Fremgangsmate og midler for behandling av inflammatorisk tarmsykdom
WO2006073682A3 (en) Diagnostic test
EA201000131A1 (ru) Диагностика, определение стадии и мониторинг воспалительного заболевания кишечника
AR107561A2 (es) Ensayo elisa para la detección de vegf
CN101541357B (zh) 肝病的治疗
Rose et al. Mycophenolate mofetil decreases antibody production after cardiac transplantation
EP2139428A4 (en) Cell separation device and method for its use
WO2006127861A3 (en) Diagnosis of diseases and conditions by analysis of histopathologically processed biological samples using liquid tissue preparations
DE602005024810D1 (de) Verfahren zum frühen nachweis einer nierenkrankheit und -verletzung
JP2007527287A5 (zh)
ATE517577T1 (de) Atementnahmevorrichtung
WO2003064994A3 (en) Methods of collecting and analyzing human breath
WO2006084299A8 (en) Method for evaluating the allergen sensitivity of an individual
Zhou et al. The role of donor-derived cell-free DNA in the detection of renal allograft injury
WO2006089219A3 (en) Neoepitope detection of disease using protein arrays
Remuzzi et al. Albumin concentration in the Bowman's capsule: multiphoton microscopy vs micropuncture technique
CN105177152A (zh) 检测hla-b*51等位基因的方法和引物
CN110295228A (zh) 检测gata2的物质在制备诊断活动性结核病的试剂盒中的应用
WO2008093076A3 (en) Assays and therapy
ATE487692T1 (de) Verfahren und verbindungen zum nachweis von medizinischen erkrankungen
Hallden et al. Conditions in blood sampling procedures that extend the ex vivo stability of eosinophil activity markers in peripheral blood from allergic patients and healthy controls
Tandarto et al. miR-155 EXPRESSION UTILIZATION AS A POTENTIAL DIAGNOSTIC BIOMARKER OF HEART FAILURE: A SYSTEMATIC REVIEW: Received 2023-01-03; Accepted 2023-02-09; Published 2023-03-09
Lee et al. Association of high body lead store with severe intracranial carotid atherosclerosis
Guimbal et al. Mast cells participate in the development of diastolic dysfunction in diabetic obese mice
ATE545027T1 (de) Probensammelverfahren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application